Investors

Date	Name	Title	Type	Shares Traded	Price Range
Oct 6, 2010	brown michael s	Director	Automatic Sell	3,235	29.05
Oct 7, 2010	brown michael s	Director	Automatic Sell	1,765	28.03
Oct 13, 2010	sanofi	Beneficial Owner (10% or more)	Buy	1,017,401	28.00
Oct 20, 2010	gilman alfred g	Director	Disposition (Non Open Market)	9,000	n/a
Oct 21, 2010	gilman alfred g	Director	Disposition (Non Open Market)	1,000	n/a
Nov 23, 2010	goldstein joseph l	Director	Option Execute	10,000	15.01 - 18.80
Nov 23, 2010	goldstein joseph l	Director	Automatic Sell	5,669	29.81
Nov 23, 2010	shooter eric m	Director	Option Execute	7,500	19.69
Nov 23, 2010	shooter eric m	Director	Automatic Sell	7,500	30.00
Nov 23, 2010	vagelos p roy	Director	Automatic Sell	30,000	30.03
Nov 24, 2010	goldstein joseph l	Director	Automatic Sell	4,331	30.06
Dec 16, 2010	goldberg murray a	Officer	Option Execute	16,250	13.00
Dec 16, 2010	goldberg murray a	Officer	Automatic Sell	11,082	31.80
Dec 16, 2010	goldberg murray a	Officer	Option Execute	16,250	13.00
Dec 16, 2010	goldberg murray a	Officer	Automatic Sell	11,082	31.80
Dec 16, 2010	goldstein joseph l	Director	Option Execute	10,000	15.01
Dec 16, 2010	goldstein joseph l	Director	Automatic Sell	4,719	31.80
Dec 16, 2010	vagelos p roy	Director	Automatic Sell	17,384	32.04
Dec 16, 2010	van plew daniel p	Officer	Option Execute	25,000	20.90
Dec 16, 2010	van plew daniel p	Officer	Automatic Sell	25,000	32.00
Showing 181-200 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.